Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hyundai Motor (005380) – Change in Representative Directors (Appointment of Executive Vice President Young-Il Choi)

Posted on March 26, 2026July 23, 2026 By K-STOCK Editor No Comments on [Disclosure] Hyundai Motor (005380) – Change in Representative Directors (Appointment of Executive Vice President Young-Il Choi)

Fact Source: Financial Supervisory Service DART / 2026-03-26

Disclosure Type: Notice of Change in Representative Director (Executive Officer)

💡 3-Second Summary

Hyundai Motor appointed Executive Vice President Young-Il Choi as a new Representative Director, transitioning from a 2-person to a 3-person independent (sole) Representative Director structure alongside Euisun Chung and José Muñoz Barceló.

📊 1. [Key Disclosure Content & Summary of Figures]

  • Previous Representative Directors: Euisun Chung, Muñoz Barceló José Antonio (Independent Representative Directors)
  • New Representative Directors: Euisun Chung, Muñoz Barceló José Antonio, Young-Il Choi (Independent Representative Directors)
  • Reason for Change: New appointment of Young-Il Choi
  • Effective Date: March 26, 2026 (Date of Board Resolution)
  • Profile of Newly Appointed Representative Director:
    • Name: Young-Il Choi
    • Relationship to Largest Shareholder: Specially related person to the largest shareholder
    • Key Experience: Executive Vice President of Hyundai Motor, Domestic Production / Chief Safety Officer (CSO) (Current); Senior Vice President, Head of Hyundai Production Engineering Center (Former)

📈 2. [Expert Perspective: What This Filing Means for Investors]

This filing serves as a corporate governance notification regarding changes in Hyundai Motor’s executive leadership structure. No financial metrics or earnings figures are included in this disclosure text.

Following the Board of Directors resolution, Young-Il Choi was newly appointed, establishing a 3-person independent Representative Director framework. Investors can observe the factual update in executive appointments and leadership structure as detailed in the filing.

📝 Editor’s Comment (by K-STOCK Editor)

This announcement provides official notice of executive management restructuring following a new Representative Director appointment. Because the filing document omits standalone financial figures or target metrics, analysis remains focused on the presented organizational change.

Investors can review the updated 3-person independent Representative Director framework, incorporating Executive Vice President Young-Il Choi alongside Executive Chair Euisun Chung and President José Muñoz Barceló.

📢 Disclaimer & Source Notice

Source: This content was newly generated and structured based on official submission data from the Financial Supervisory Service DART.

Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Automotive

Post navigation

Previous Post: [Disclosure] Hyundai Motor (005380) – Results of the 58th Annual General Meeting of Shareholders (Approval of Financial Statements, Dividends, Business Purpose Amendment, and Director Elections)
Next Post: [Disclosure] Jusung Engineering (036930) Approves Q1 Financial Ledgers and Finalizes KRW 53 per Share Cash Dividend at Annual Shareholder Meeting

Related Posts

[Disclosure] SK hynix (000660) Designates September 30 as Record Date for Q3 24 Quarterly Cash Dividend Entitlements Semiconductors
[Disclosure] Hanwha Ocean (042660) Discloses Board Report on 2025 Operation Results and 2026 Plans for Compliance Program (CP) Disclosures
[Disclosure] Hyundai Motor (005380) – Decision on Record Date (May 31, 2026) for Quarterly Cash Dividend Disclosures
[Disclosure] Celltrion (068270), Submits Phase 3 Clinical Trial Application for CT-P13 SC in Europe (Part 1&2) (Rheumatoid Arthritis Patients) Disclosures
[Disclosure] Celltrion (068270) Corrects and Finalizes 2023 Fiscal Year-End Cash Dividend to Approximately KRW 103.6 Billion Disclosures
[Disclosure] Celltrion (068270), Obtains Positive CHMP Opinion Under the European Medicines Agency (EMA) for CT-P43 (Stelara Biosimilar) Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme